Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Strategy and regulatory pathway for StemCART - A stem cell derived cartilage repair product
| Reference number | 2023-04008 |
| Coordinator | Cline Scientific AB |
| Funding from Vinnova | SEK 180 000 |
| Project duration | January 2024 - August 2024 |
| Status | Ongoing |
| Venture | Medtech4Health: Competence Enhancement in SME |
| Call | Medtech4Health: Skills enhancement in small businesses 2023 |
Last updated 19 December 2024
Reference number 2023-04008
